Mativ Holdings, Inc. — Q1 2024 Form 10-Q
Business context and reporting period. Unaudited results cover the three months ended March 31, 2024, compared with Q1 2023. Mativ is a global specialty materials manufacturer. Following the November 2023 sale of its Engineered Papers business, that business is reported as discontinued operations; comparisons below are generally on a continuing-operations basis. In Q1 2024, Mativ reorganized into Filtration & Advanced Materials (FAM) and Sustainable & Adhesive Solutions (SAS); prior segment figures were recast.
Financial performance
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net sales | $500.2 million | $549.0 million |
| Gross profit / margin | $84.0 million / 16.8% | $87.7 million / 16.0% |
| Operating loss | $13.8 million | $2.2 million |
| Continuing-operations net loss | $28.0 million | $15.5 million |
| Continuing-operations diluted loss per share | $0.52 | $0.28 |
| Cash used in operating activities | $13.0 million | $24.4 million |
| Capital spending | $12.1 million | $14.1 million |
| Interest expense | $18.3 million | $15.6 million |
Sales fell $48.8 million, or 8.9%. FAM sales declined 8.1% to $202.7 million and SAS sales declined 9.4% to $297.5 million. Management cited lower volumes and selling prices, customer caution, and—in FAM—lower demand for advanced films and coatings; favorable currency translation partly offset the declines. Gross profit decreased 4.2%, but margin improved to 16.8% from 16.0% as favorable input costs versus selling prices and cost-reduction actions more than offset lower volumes, weaker fixed-cost absorption, and higher production costs. Operating loss widened principally amid higher restructuring charges.
FAM operating income was $14.6 million, down from $27.2 million; SAS operating income was $4.2 million, down from $5.1 million. Q1 2023 included $7.8 million of income from discontinued operations, so reported total net loss was $7.7 million then, versus $28.0 million in Q1 2024.
Liquidity, debt, and cash flow
At March 31, 2024, cash was $128.9 million, total debt was $1,158.0 million, and unused capacity under the $600 million revolver was $279.6 million. Net leverage under the credit agreement was 4.2x against a 4.50x maximum covenant; the company reported compliance with its credit agreement and note covenants. The nearest significant maturity is $350 million of 6.875% senior notes due in 2026. The weighted-average effective interest rate on debt, including hedges, was approximately 5.94% for the quarter, versus 5.63% a year earlier.
Operating cash use improved year over year, with working-capital outflows of $12.7 million versus $46.1 million. Cash nevertheless increased $8.7 million to $128.9 million, supported by $52.3 million of net debt proceeds; financing included $69.0 million of borrowings and $16.7 million of debt repayments. Accounts receivable rose to $225.8 million from $176.5 million at year-end. Management said available liquidity is sufficient for anticipated needs for the foreseeable future; $107.5 million of cash was held by foreign subsidiaries.
Material changes, outlook, and risks
- Restructuring and impairment expense rose to $14.4 million from $0.8 million. The new organizational realignment plan accounted for $12.7 million, primarily severance. Management expected plan activities to finish in 2024, with additional plan costs not expected to exceed $7 million. Separate facility-closure costs were also expected during the remainder of 2024: $2.0–$2.5 million in FAM and $1.0–$1.5 million in SAS.
- Management cited an uncertain economic environment and customer caution affecting volumes. Favorable cost and pricing effects and cost-reduction initiatives provided partial offsets. The filing provides no specific sales, earnings, or margin guidance.
- The company declared a $0.10-per-share dividend payable June 21, 2024, subject to record-date terms. It said dividend policy will be assessed in light of strategy, cash generation, debt, and funding needs.
- Key disclosed risks include weaker demand, pricing and production-cost pressure, supply-chain disruption, inflation, interest- and foreign-exchange-rate movements, debt and covenant capacity, execution of restructuring and strategic initiatives, and environmental obligations. No material litigation was reported; the company noted environmental matters could create additional costs. It reported no material change to the risk factors in its 2023 Form 10-K.
Investor verification priorities
- Track whether sales volumes and segment operating performance stabilize, particularly given continued customer caution and lower selling prices.
- Monitor working capital and operating cash generation, including the increase in receivables, alongside reliance on revolver borrowings.
- Check leverage and covenant headroom: reported net leverage was 4.2x versus the 4.50x limit, and the 2026 senior-note maturity is approaching.
- Verify restructuring costs, completion timing, and whether anticipated cost savings offset charges and operating pressures.
- Assess the effect of the discontinued Engineered Papers business and the new segment structure when comparing future periods.